Shuichi Yamada

Effect of CRISPR/Cas9-Mediated PD-1-Disrupted Primary Human Third-Generation CAR-T Cells Targeting EGFRvIII on In Vitro Human Glioblastoma Cell Growth

Tsutomu Nakazawa, Atsushi Natsume, Fumihiko Nishimura et al. · Cells · 2020 · 103 citations · Full text

Medicine, Biotechnology, Oncology +17

CRISPR-Cas9–Mediated TIM3 Knockout in Human Natural Killer Cells Enhances Growth Inhibitory Effects on Human Glioma Cells

Takayuki Morimoto, Tsutomu Nakazawa, Ryosuke Matsuda et al. · International Journal of Molecular Sciences · 2021 · 71 citations · Full text

Life Sciences, Immunology, Oncology +17

Enhanced Hematoma Membrane on DynaCT Images During Middle Meningeal Artery Embolization for Persistently Recurrent Chronic Subdural Hematoma

Ichiro Nakagawa, Hun Soo Park, Masashi Kotsugi et al. · World Neurosurgery · 2019 · 53 citations

Medicine, Neurosurgery, Radiology +16

Platelet inhibition by adjunctive cilostazol suppresses the frequency of cerebral ischemic lesions after carotid artery stenting in patients with carotid artery stenosis

Ichiro Nakagawa, Takeshi Wada, Hun Soo Park et al. · Journal of Vascular Surgery · 2013 · 33 citations

Medicine, Hematology, Pharmacotherapy +17

Investigation of poststroke epilepsy (INPOSE) study: a multicenter prospective study for prediction of poststroke epilepsy

Shuichi Yamada, Ichiro Nakagawa, Kentaro Tamura et al. · Journal of Neurology · 2020 · 29 citations

Medicine, Neurology, Neuroscience +10